Klinikum Vest - Knappschaftskrankenhaus, Recklinghausen Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2014
NCT02144077
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Klinik fuer Dermatologie und Allergologie (Klinikum Vest - Knappschaftskrankenhaus), Recklinghausen, Germany | Klinikum Vest GmbH, Knappschaftskrankenhaus Recklinghausen | KLINIKUM VEST GMBH Knappschaftskrankenhaus Recklinghausen

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 3)

Carcinoma, Basal Cell (Phase 3)

Hyperhidrosis (Phase 3)

Onychomycosis (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 3